Equillium, Inc. (EQ) income statement
EQNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.12+0.02 (+1.82%)
Close on Nov 19, 2026Market cap $71.02MP/E –Yield –
Equillium, Inc. financial ratios
See a number that looks wrong?
Close on Nov 19, 2026Market cap $71.02MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Margins | |||||||||
| Operating margin | – | -20.1% | -40.2% | -393.9% | – | – | – | – | – |
| EBITDA margin | – | – | – | -393.2% | – | – | – | – | – |
| Pre-tax margin | – | -18.8% | -35.3% | -396.1% | – | – | – | – | – |
| Net profit margin | – | -19.6% | -37.0% | -396.1% | – | – | – | – | – |
| Free cash flow margin | – | -46.5% | -60.5% | -57.2% | – | – | – | – | – |
| Returns on capital | |||||||||
| Return on equity | -94.0% | -38.8% | -48.9% | -126.8% | -57.3% | -53.4% | -47.9% | -42.3% | – |
| Return on assets | -77.9% | -21.2% | -20.7% | -76.2% | -45.7% | -42.3% | -41.7% | -35.7% | – |
| Return on tangible assets | -77.9% | -21.2% | -20.7% | -76.2% | -45.7% | -42.3% | -41.7% | -35.7% | – |
| Return on invested capital | – | – | – | 287.4% | 929.6% | 1,174.2% | 1,344.0% | – | – |
| Return on capital employed | -98.1% | -39.2% | -41.9% | -101.0% | -48.9% | -45.5% | -45.8% | -24.0% | – |
| Return on total capital | – | – | – | -105.6% | -48.3% | -45.0% | -51.9% | – | – |
| NOPAT | -$18.67M | -$6.53M | -$11.47M | -$49.04M | -$29.85M | -$23.34M | -$21.11M | -$6.81M | – |
| Cash flow quality | |||||||||
| OCF / Sales | – | -46.3% | -60.4% | -55.4% | – | – | – | – | – |
| OCF / Net income | 1.02 | 2.36 | 1.63 | 0.14 | 0.82 | 0.83 | 0.90 | 0.57 | – |
| FCF / OCF | 100.2% | 100.4% | 100.2% | 103.2% | 100.2% | 100.8% | 100.3% | 100.5% | – |
| FCF / Net income | 1.02 | 2.37 | 1.64 | 0.14 | 0.82 | 0.83 | 0.90 | 0.57 | – |
| FCF / EBITDA | – | – | – | 14.5% | 85.2% | 84.1% | 86.2% | 87.8% | – |
| Unlevered free cash flow | -$22.79M | -$19.11M | -$21.45M | -$8.18M | -$31.29M | -$23.96M | -$22.80M | -$5.54M | – |
| Levered free cash flow | -$22.79M | -$19.11M | -$21.83M | -$9.01M | -$32.14M | -$24.83M | -$23.02M | -$7.56M | – |
| Efficiency | |||||||||
| Asset turnover | – | 1.08 | 0.56 | 0.19 | – | – | – | – | – |
| Fixed asset turnover | – | 142.44 | 102.22 | 50.19 | – | – | – | – | – |
| Receivables turnover | – | 22.01 | 10.98 | 11.11 | – | – | – | – | – |
| Days sales outstanding | – | 16.6 | 33.2 | 32.9 | – | – | – | – | – |
| CapEx to revenue | – | 0.21% | 0.14% | 1.8% | – | – | – | – | – |
| CapEx to OCF | -0.21% | -0.45% | -0.23% | -3.2% | -0.18% | -0.82% | -0.32% | -0.47% | – |
| CapEx to depreciation | – | – | – | 2.36 | 0.79 | 4.49 | 3.22 | 5.83 | – |
| Liquidity | |||||||||
| Current ratio | 10.58 | 3.93 | 1.79 | 2.40 | 9.35 | 11.76 | 14.28 | 33.09 | 12.57 |
| Quick ratio | 10.58 | 3.93 | 1.79 | 2.40 | 9.35 | 11.76 | 14.28 | 33.09 | 12.57 |
| Cash ratio | 10.32 | 3.56 | 1.48 | 2.22 | 9.05 | 11.35 | 13.67 | 32.50 | 12.49 |
| Working capital | $28.10M | $18.62M | $21.78M | $44.70M | $74.46M | $77.93M | $51.55M | $65.07M | $6.58M |
| Net current asset value | $27.75M | $18.44M | $21.39M | $30.26M | $64.47M | $69.60M | $41.74M | $64.87M | -$2.25M |
| Leverage | |||||||||
| Total debt | – | – | – | $8.95M | $10.18M | $9.94M | $9.68M | – | – |
| Net debt | – | – | – | -$62.05M | -$70.52M | -$72.26M | -$43.42M | – | – |
| Debt / Equity | – | – | – | 0.28 | 0.15 | 0.14 | 0.23 | – | – |
| Debt ratio | – | – | – | 11.4% | 11.9% | 11.6% | 17.4% | – | – |
| Assets to equity | 1.12 | 1.34 | 2.24 | 2.46 | 1.28 | 1.22 | 1.33 | 1.03 | -3.18 |
| Long-term debt to assets | – | – | – | 4.1% | 10.2% | 9.7% | 17.4% | – | – |
| Long-term debt to equity | – | – | – | 0.10 | 0.13 | 0.12 | 0.23 | – | – |
| Total debt / Capitalization | – | – | – | 21.9% | 13.3% | 12.5% | 18.8% | – | – |
| Long-term debt / Capitalization | – | – | – | 9.2% | 11.6% | 10.6% | 18.8% | – | – |
| Net debt / EBITDA | – | – | – | 1.00 | 1.87 | 2.45 | 1.63 | – | – |
| Total debt / EBITDA | – | – | – | -0.14 | -0.27 | -0.34 | -0.36 | – | – |
| Cash flow to debt | – | – | – | -97.5% | -315.2% | -247.7% | -237.1% | – | – |
| Interest coverage | |||||||||
| EBIT / Interest expense | – | – | -29.58 | -58.95 | -35.22 | -26.89 | -95.80 | -3.37 | – |
| EBITDA / Interest expense | – | – | – | -58.84 | -35.15 | -26.85 | -95.71 | -3.37 | – |
| (EBITDA − CapEx) / Interest expense | – | – | – | -59.10 | -35.20 | -27.03 | -95.98 | -3.38 | – |
| Per share | |||||||||
| Revenue per share | – | 1.16 | 1.02 | 0.46 | – | – | – | – | – |
| EPS (basic) | -0.39 | -0.23 | -0.38 | -1.85 | -1.36 | -1.46 | -1.47 | -1.09 | – |
| EPS (diluted) | -0.39 | -0.23 | -0.38 | -1.85 | -1.36 | -1.46 | -1.47 | -1.09 | – |
| Book value per share | 0.47 | 0.54 | 0.64 | 0.93 | 2.26 | 2.82 | 2.40 | 3.74 | -0.21 |
| Tangible book value per share | 0.47 | 0.54 | 0.64 | 0.93 | 2.26 | 2.82 | 2.40 | 3.74 | -0.21 |
| Cash per share | 0.49 | 0.64 | 1.16 | 2.06 | 2.74 | 3.32 | 3.05 | 3.79 | 0.66 |
| Operating cash flow per share | -0.37 | -0.54 | -0.62 | -0.25 | -1.09 | -0.99 | -1.32 | -0.43 | – |
| Free cash flow per share | -0.37 | -0.54 | -0.62 | -0.26 | -1.09 | -1.00 | -1.32 | -0.44 | – |
| CapEx per share | 0.0008 | 0.0024 | 0.0014 | 0.0081 | 0.0019 | 0.0082 | 0.0042 | 0.0020 | – |
| Valuation at period end | |||||||||
| Market cap | $94.05M | $26.50M | $25.39M | $36.41M | $110.77M | $132.28M | $58.73M | $90.82M | – |
| Enterprise value | $60.93M | $604.53K | -$20.91M | $2.24M | $30.20M | $51.65M | $6.15M | $85.84M | – |
| P/S | – | 0.6x | 0.7x | – | – | – | – | – | – |
| P/B | 3.3x | 1.4x | 1.1x | 1.1x | 1.7x | 1.9x | 1.4x | 1.4x | – |
| P/TBV | 3.3x | 1.4x | 1.1x | 1.1x | 1.7x | 1.9x | 1.4x | 1.4x | – |
| P/OCF | -4.1x | -1.4x | -1.2x | -4.2x | -3.5x | -5.4x | -2.6x | -12.1x | – |
| EV/Sales | – | 0.0x | -0.6x | – | – | – | – | – | – |
| EV/EBIT | – | – | 1.4x | – | – | – | – | – | – |
| EV/OCF | -2.7x | -0.0x | 1.0x | -0.3x | -0.9x | -2.1x | -0.3x | -11.4x | – |
| EV/FCF | – | – | 1.0x | – | – | – | – | – | – |
| Earnings yield | -23.8% | -30.4% | -52.5% | -171.4% | -35.3% | -22.5% | -43.6% | -14.6% | – |
| FCF yield | -24.2% | -72.1% | -86.0% | -24.7% | -29.0% | -18.8% | -39.2% | -8.3% | – |
| Shareholder yield | |||||||||
| Buyback yield | – | – | 1.0% | – | – | – | – | – | – |
| Shareholder yield | – | – | 1.0% | – | – | – | – | – | – |
| Cost structure | |||||||||
| R&D to revenue | – | 91.1% | 102.6% | 238.3% | – | – | – | – | – |
| Stock-based comp to revenue | – | 9.1% | 11.1% | 30.7% | – | – | – | – | – |
| Per employee | |||||||||
| Total employees | 14 | 35 | 44 | 36 | 45 | 31 | 16 | 11 | 11 |
| Revenue per employee | – | $1.17M | $820.09K | – | – | – | – | – | – |
| Operating profit per employee | -$1.69M | -$236.26K | -$330.05K | -$1.72M | -$839.69K | -$953.16K | -$1.67M | -$783.18K | – |
| Net income per employee | -$1.60M | -$230.49K | -$303.07K | -$1.73M | -$867.82K | -$961.71K | -$1.60M | -$1.20M | – |
| Free cash flow per employee | -$1.63M | -$546.03K | -$496.20K | -$250.33K | -$714.18K | -$800.84K | -$1.44M | -$687.36K | – |
| Growth | |||||||||
| Revenue 1Y growth | – | 13.9% | 129.0% | – | – | – | – | – | – |
| EBIT 1Y growth | -185.8% | 43.1% | 76.6% | -64.3% | -27.9% | -10.6% | -210.2% | – | – |
| EBITDA 1Y growth | – | – | – | -64.3% | -27.8% | -10.5% | -210.2% | – | – |
| Net income 1Y growth | -177.6% | 39.5% | 78.6% | -59.9% | -31.0% | -16.5% | -93.2% | – | – |
| Diluted EPS 1Y growth | -69.6% | 39.5% | 79.5% | -36.0% | 6.8% | 0.68% | -34.9% | – | – |
| Operating cash flow 1Y growth | -19.6% | 12.7% | -149.4% | 72.8% | -30.3% | -7.3% | -204.9% | – | – |
| Free cash flow 1Y growth | -19.3% | 12.5% | -142.3% | 72.0% | -29.5% | -7.8% | -204.5% | – | – |
| CapEx 1Y growth | -43.5% | 70.0% | -82.1% | 389.5% | -71.8% | 173.0% | 111.4% | – | – |
| CapEx 3Y CAGR | -44.4% | 14.2% | -37.2% | 55.6% | 17.7% | – | – | – | – |
| CapEx 5Y CAGR | -25.0% | 2.8% | 7.4% | – | – | – | – | – | – |
| Total assets 1Y growth | 24.5% | -49.3% | -35.6% | -8.2% | -0.03% | 53.8% | -17.3% | 839.2% | – |
| Total assets 3Y CAGR | -25.9% | -33.1% | -16.1% | 12.2% | 8.3% | 128.6% | – | – | – |
| Total assets 5Y CAGR | -17.9% | -14.3% | -5.5% | 61.4% | – | – | – | – | – |
| Total equity 1Y growth | 50.0% | -15.6% | -29.3% | -52.0% | -4.8% | 66.9% | -35.6% | 2,983.4% | – |
| Total equity 3Y CAGR | -3.6% | -34.1% | -31.4% | -8.6% | 0.80% | – | – | – | – |
| Total equity 5Y CAGR | -16.4% | -14.6% | -19.0% | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.